Literature DB >> 21194148

Cerebral pseudoatrophy or real atrophy after therapy in multiple sclerosis.

Samia Khoury, Rohit Bakshi.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 21194148     DOI： 10.1002/ana.22254

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  9 in total

1.  Approaches to normalization of spinal cord volume: application to multiple sclerosis.

Authors:  Brian C Healy; Ashish Arora; Douglas L Hayden; Antonia Ceccarelli; Shahamat S Tauhid; Mohit Neema; Rohit Bakshi
Journal:  J Neuroimaging       Date:  2011-08-19       Impact factor: 2.486

Review 2.  Imaging as an Outcome Measure in Multiple Sclerosis.

Authors:  Daniel Ontaneda; Robert J Fox
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

3.  Randomized study combining interferon and glatiramer acetate in multiple sclerosis.

Authors:  Fred D Lublin; Stacey S Cofield; Gary R Cutter; Robin Conwit; Ponnada A Narayana; Flavia Nelson; Amber R Salter; Tarah Gustafson; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2013-03-11       Impact factor: 10.422

4.  Fludarabine add-on therapy in interferon-beta-treated patients with multiple sclerosis experiencing breakthrough disease.

Authors:  Steven J Greenberg; Robert Zivadinov; Peterkin Lee-Kwen; Jitendra Sharma; Margaret Planter; Margaret Umhauer; Norman Glenister; Rohit Bakshi
Journal:  Ther Adv Neurol Disord       Date:  2016-01-21       Impact factor: 6.570

Review 5.  The effect of disease modifying therapies on brain atrophy in patients with relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.

Authors:  Georgios Tsivgoulis; Aristeidis H Katsanos; Nikolaos Grigoriadis; Georgios M Hadjigeorgiou; Ioannis Heliopoulos; Constantinos Kilidireas; Konstantinos Voumvourakis
Journal:  PLoS One       Date:  2015-03-10       Impact factor: 3.240

6.  Quantification of global cerebral atrophy in multiple sclerosis from 3T MRI using SPM: the role of misclassification errors.

Authors:  Elisa Dell'Oglio; Antonia Ceccarelli; Bonnie I Glanz; Brian C Healy; Shahamat Tauhid; Ashish Arora; Nikila Saravanan; Matthew J Bruha; Alexander V Vartanian; Sheena L Dupuy; Ralph H B Benedict; Rohit Bakshi; Mohit Neema
Journal:  J Neuroimaging       Date:  2014-12-18       Impact factor: 2.486

7.  Serum lipid antibodies are associated with cerebral tissue damage in multiple sclerosis.

Authors:  Rohit Bakshi; Ada Yeste; Bonny Patel; Shahamat Tauhid; Subhash Tummala; Roya Rahbari; Renxin Chu; Keren Regev; Pia Kivisäkk; Howard L Weiner; Francisco J Quintana
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-01-27

8.  The Effect of Dimethyl Fumarate on Cerebral Gray Matter Atrophy in Multiple Sclerosis.

Authors:  Sheena L Dupuy; Shahamat Tauhid; Shelley Hurwitz; Renxin Chu; Fawad Yousuf; Rohit Bakshi
Journal:  Neurol Ther       Date:  2016-10-15

9.  Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliability.

Authors:  Renxin Chu; Shelley Hurwitz; Shahamat Tauhid; Rohit Bakshi
Journal:  BMC Neurol       Date:  2017-09-05       Impact factor: 2.474
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.